304
Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051–1052.
305
www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm
306
www.herceptin.com/herceptin/physician/pi.htm
307
Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332–443.
308
Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.
309
Daily Mail, Monday, 9 October, 2006.
310
www.ahrq.gov/news/press/pr2002/brchempr.htm
311
www.ahrq.gov/news/press/pr2002/brchempr.htm
312
http://cis.nci.nih.gov/fact/7_16.htm
313
Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.
314
http://cis.nci.nih.gov/fact/7_16.htm
315
Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539
316
www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm
317
http://cis.nci.nih.gov/fact/7_45.htm
318
New Scientist, 20 January, 2007.
319
Editorial, New Scientist, 31 March, 2007.
320
Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.
321
Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269–271.
322
www.cancer.gov
323
Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99–1136: www.cancer.gov/cancerinfo/chemorherapy-and-you
